» Articles » PMID: 7013276

Disorders of Platelet Function: Mechanisms, Diagnosis and Management

Overview
Journal West J Med
Specialty General Medicine
Date 1981 Feb 1
PMID 7013276
Citations 2
Authors
Affiliations
Soon will be listed here.
Abstract

Platelets play an important role in hemostasis, and alterations in platelet function may be the cause of abnormal bleeding in a wide variety of congenital and acquired clinical disorders. Platelet dysfunction may be classified as disorders of (1) substrate connective tissue, (2) adhesion, (3) aggregation and (4) platelet-release reaction. The congenital defects of platelet function, although uncommon, have provided important insights into platelet physiology and pathophysiology and, as a group, are less common, better characterized and more readily classified than the acquired defects. The severity of bleeding resulting from platelet dysfunction varies greatly and is substantially increased when another defect of hemostasis coexists. A disorder of platelet function is suspected on the basis of the history and physical examination and is confirmed by the finding of a prolonged bleeding time in the presence of an adequate number of platelets. A specific diagnosis often requires measurements of the factor VIII and von Willebrand factor complex and other tests of platelet function. Some of these tests may be available only in specialized laboratories. Therapy for bleeding episodes resulting from platelet dysfunction is directed at (1) removing or treating the underlying cause of the platelet disorder; (2) replacing the missing plasma cofactors needed to support normal platelet function (such as by the transfusion of cryoprecipitate in patients with von Willebrand disease, and (3) transfusing functional platelets in the form of platelet concentrates in patients with disorders of intrinsic platelet dysfunction.

Citing Articles

Platelet dysfunction and migraines.

Kudrow L West J Med. 1981; 134(5):454-5.

PMID: 7257358 PMC: 1272795.


The effect of oral phenylbutazone on whole blood platelet aggregation in the dog.

Jackson M, Searcy G, Olexson D Can J Comp Med. 1985; 49(3):271-7.

PMID: 3930056 PMC: 1236170.

References
1.
Castaldi P, Rozenberg M, Stewart J . The bleeding disorder of uraemia. A qualitative platelet defect. Lancet. 1966; 2(7454):66-9. DOI: 10.1016/s0140-6736(66)91802-2. View

2.
Weiss H . The effect of clinical dextran on platelet aggregation, adhesion, and ADP release in man: in vivo and in vitro studies. J Lab Clin Med. 1967; 69(1):37-46. View

3.
Mielke Jr C, Kaneshiro M, Maher I, Weiner J, RAPAPORT S . The standardized normal Ivy bleeding time and its prolongation by aspirin. Blood. 1969; 34(2):204-15. View

4.
Perkins H, Mackenzie M, Fudenberg H . Hemostatic defects in dysproteinemias. Blood. 1970; 35(5):695-707. View

5.
HOROWITZ H, Stein I, Cohen B, White J . Further studies on the platelet-inhibitory effect of guanidinosuccinic acid and its role in uremic bleeding. Am J Med. 1970; 49(3):336-45. DOI: 10.1016/s0002-9343(70)80025-0. View